Autoinmune Hepatitis: Up-to-Date Concepts
DOI:
https://doi.org/10.52787/agl.v53i1.309Keywords:
Autoimmune hepatitis, interphase hepatitis, emperipolesisAbstract
Autoimmune hepatitis is a rare pathology characterized by biochemical and histological alterations. Two subtypes are known: type I affects children and adults, and type II affects almost exclusively children. So far there are no specific diagnostic criteria and it is considered a pathology of exclusion, although there are certain laboratory and histological alterations related to this entity. It can be asymptomatic or symptomatic, and the treatment of choice is immunosuppression. The use of non-invasive methods such as elastography can be useful in follow-up surveillance, both to evaluate treatment and to prevent complications. In its evolution it can present advanced hepatic fibrosis, cirrhosis, requirement of liver transplantation and death due to hepatic insuffieciency. The aim of this review is to present the latest evidence related to autoimmune hepatitis.
References
-1. Pape S, et al Sistematicrewiew of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group, J. Hepatol. 2022,76,841-849.
-2. Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int. 2021 Apr;15(2):223-257. DOI: 10.1007/s12072-021-10170-1. Epub 2021 May 4. PMID: 33942203; PMCID: PMC8144150.
-3. Terziroli Beretta-Piccoli, B., Mieli-Vergani, G. &Vergani, D. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. ClinicRevAllergImmunol 63, 124-137 (2022). https://doi.org/10.1007/s12016-021-08888-9
-4. Mack, C.L., Adams, D., Assis, D.N., Kerkar, N., Manns, M.P., Mayo, M.J., Vierling, J.M., Alsawas, M., Murad, M.H. and Czaja, A.J. (2020), Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology, 72:671-722. https://doi.org/10.1002/hep.31065
-5. Mieli-Vergani G, Vergani D, Czaja AJ, Manns MP, Krawitt EL, Vierling JM, Lohse AW, Montano-Loza AJ. Autoimmune hepatitis. Nat Rev Dis Primers. 2018 Apr 12;4:18017. DOI: 10.1038/nrdp.2018.17. PMID: 29644994.
-6. Bhumi SA, Wu GY. Seronegative Autoimmune Hepatitis. J Clin Transl Hepatol. 2023 Apr 28;11(2):459-465. DOI: 10.14218/JCTH.2022.00235. Epub 2022 Sep 26. PMID: 36643052; PMCID: PMC9817061.
-7. Harrington, C, Krishnan, S, Mack, CL, Cravedi, P, Assis, DN, Levitsky, J. Noninvasive biomarkers for the diagnosis and management of autoimmune hepatitis. Hepatology. 2022;76: 1862-1879. https://doi.org/10.1002/hep.32591
-8. Ni XX, Lian M, Wu HM, Li XY, Sheng L, Bao H, Miao Q, Xiao X, Guo CJ, Li H, Ma X, Hua J. Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases. World J Gastroenterol. 2021 Jan 7;27(1):80-91. DOI: 10.3748/wjg.v27.i1.80. PMID: 33505152; PMCID: PMC7789069.
-9. Gurung A, Assis DN, McCarty TR, Mitchell KA, Boyer JL, Jain D. Histologic features of autoimmune hepatitis: a critical appraisal. Hum Pathol. 2018;82:51-60. DOI: 10.1016/j.humpath.2018.07.014
-10. Lohse AW, Sebode M, Bhathal PS, Clouston AD, Dienes HP, Jain D, Gouw ASH, Guindi M, Kakar S, Kleiner DE, Krech T, Lackner C, Longerich T, Saxena R, Terracciano L, Washington K, Weidemann S, Hübscher SG, Tiniakos D. Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. Liver Int. 2022 May;42(5):1058-1069. DOI: 10.1111/liv.15217. Epub 2022 Mar 12. PMID: 35230735.
-11. Hartl J, Ehlken H, Sebode M, Peiseler M, Krech T, Zenouzi R, von Felden J, Weiler-Normann C, Schramm C, Lohse AW. Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis. J Hepatol. 2018 Apr;68(4):754-763. DOI: 10.1016/j.jhep.2017.11.020. Epub 2017 Nov 24. PMID: 29180000.
-12. Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, Hübener S, Pannicke N, Weiler-Normann C, Quaas A, Lohse AW, Schramm C. Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis. J Hepatol. 2016 Oct;65(4):769-775. DOI: 10.1016/j.jhep.2016.05.023. Epub 2016 May 26. PMID: 27238753.
-13. Yan YL, Xing X, Wang Y, Wang XZ, Wang Z, Yang L. Clinical utility of two-dimensional shear-wave elastography in monitoring disease course in autoimmune hepatitis-primary biliary cholangitis overlap syndrome. World J Gastroenterol. 2022 May 14;28(18):2021-2033. DOI: 10.3748/wjg.v28.i18.2021. PMID: 35664960; PMCID: PMC9150059.
-14. Efe, C, Kulkarni, AV, Terziroli Beretta-Piccoli, B, Magro, B, Stättermayer, A, Cengiz, M, et al. Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome. Hepatology.2022;76:1576-1586. https://doi.org/10.1002/hep.32572
-15. Purnak T, Efe C, Kav T, Wahlin S, Ozaslan E. Treatment response and outcome with two different prednisolone regimens in autoimmune hepatitis. Dig Dis Sci 2017;62(10):2900-2907.
-16. Pape S, Gevers TJG, Belias M, Mustafajev IF, Vrolijk JM, van Hoek B, et al. Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis. Clin GastroenterolHepatol 2019;17(10):2068-2075.e2
-17. Beretta-Piccoli BT, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol 2017;23(33):6030-6048
-18. Newman WG, Payne K, Tricker K, Roberts SA, Fargher E, Pushpakom S, et al. A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to aza- thioprine treatment: the TARGET study. Pharmacogenomics 2011;12(6):815-826.
-19. Rodríguez Y, Rojas M, Beltrán S, Polo F, Camacho-Domínguez L, Morales SD, Gershwin ME, Anaya JM. Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. J Autoimmun. 2022 Oct;132:102898. DOI: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24. PMID: 36041291; PMCID: PMC9399140.
-20. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; Clinical Practice Guideline Panel; Chair; EASL Governing Board representative; Panel members. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021 Sep;75(3):659-689. DOI: 10.1016/j.jhep.2021.05.025. Epub 2021 Jun 21. PMID: 34166721.
-21. Front. Immunol., 25 November 2022Sec. Autoimmune and Autoinflammatory Disorders: Autoimmune Disorders Volume 13-2022. https://doi.org/10.3389/fimmu.2022.1035073
-22. Schramm C, Herkel J, Beuers U et al. (2006) Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 101:556-560. https://doi.org/10.1111/j.1572-0241.2006.00479.x
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Mónica P. Marino
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
